Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Venules01:08

Venules

Venules are an integral part of the microscopic circulatory system that bridges the gap between capillaries and veins.
Venules are much smaller in diameter compared to their larger counterparts, the veins. They are generally 8 to 100 micrometers in diameter, significantly smaller than the size of veins. The walls of venules are thin, consisting of the endothelium, a thin layer of connective tissue, and occasionally a few smooth muscle cells. This structural simplicity is a stark contrast...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort.

Journal of scleroderma and related disorders·2026
Same author

Functional characterisation of a novel homozygous p.Y227C ADA2 variant in a child with deficiency of adenosine deaminase type 2.

Clinical and experimental rheumatology·2026
Same author

Neuroimaging Findings and Treatment Update for Neuroinflammation, Autoinflammation, Splenomegaly, and Anemia, a Novel Autoinflammatory Disorder Caused by Bi-Allelic Variants in <i>IRAK4</i>.

AJNR. American journal of neuroradiology·2026
Same author

Expanding the Spectrum of Src-Family Kinase-Related Autoinflammatory Diseases: Monogenic Vasculitis Caused By Germline Pathogenic Variants in HCK and FGR.

Journal of clinical immunology·2026
Same author

A novel patient-Centered approach to clinical trial readiness in rare diseases: Application in Aicardi-Goutières Syndrome (AGS).

Molecular genetics and metabolism·2026
Same author

Case Report: Clinical application of an <i>in vitro</i> prenylation assay in the diagnosis of an early-onset case of mevalonate kinase deficiency harbouring a novel <i>MVK</i> variant.

Frontiers in pediatrics·2026
Same journal

Atypical renal phenotype with tubular proteinuria and hypercalciuria in siblings with nail-patella syndrome: evidence for a dual genetic diagnosis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Blood pressure control in pediatric hemodialysis: data from the SCOPE collaborative.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Correlation between urinary soluble CD163 and endocapillary proliferation and fibrinoid necrosis in IgA vasculitis with nephritis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

SGLT2i, anti-endothelin A and double endothelin and angiotensin inhibitors: a new future for chronic kidney disease in children.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

The role of urinary trehalase levels in the early diagnosis of acute kidney injury in dehydrated children.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Neuron-specific enolase and brain-derived neurotrophic factor as developmental neurovascular markers in chronic kidney disease and kidney transplantation.

Pediatric nephrology (Berlin, Germany)·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Rapid Whole-Mount High-Resolution Imaging of Small Animal Vasculature for Quantitative Studies
08:49

Rapid Whole-Mount High-Resolution Imaging of Small Animal Vasculature for Quantitative Studies

Published on: May 23, 2025

Small vessel vasculitis.

Paul Brogan1, Despina Eleftheriou, Michael Dillon

  • 1Department of Rheumatology, Institute of Child Health, 30 Guilford St, London, WC1N1EH, UK. p.brogan@ich.ucl.ac.uk

Pediatric Nephrology (Berlin, Germany)
|November 4, 2009
PubMed
Summary
This summary is machine-generated.

Pediatric small vessel vasculitides like Henoch-Schönlein purpura (HSP) and anti-neutrophil cytoplasmic antibody-associated vasculitides (AAV) have new classification criteria. Research gaps in clinical trial data and long-term outcomes persist for these childhood conditions.

More Related Videos

The ex vivo Isolated Skeletal Microvessel Preparation for Investigation of Vascular Reactivity
07:00

The ex vivo Isolated Skeletal Microvessel Preparation for Investigation of Vascular Reactivity

Published on: April 28, 2012

Related Experiment Videos

Last Updated: Jun 19, 2026

Rapid Whole-Mount High-Resolution Imaging of Small Animal Vasculature for Quantitative Studies
08:49

Rapid Whole-Mount High-Resolution Imaging of Small Animal Vasculature for Quantitative Studies

Published on: May 23, 2025

The ex vivo Isolated Skeletal Microvessel Preparation for Investigation of Vascular Reactivity
07:00

The ex vivo Isolated Skeletal Microvessel Preparation for Investigation of Vascular Reactivity

Published on: April 28, 2012

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Clinical Trials

Background:

  • Small vessel vasculitides in children include Henoch-Schönlein purpura (HSP) and anti-neutrophil cytoplasmic antibody-associated vasculitides (AAV).
  • Validated classification criteria for HSP and Wegener's granulomatosis (a type of AAV) are now available.
  • Understanding and treating these conditions in children presents unique challenges.

Purpose of the Study:

  • To review current knowledge on pediatric small vessel vasculitides, focusing on HSP and AAV.
  • To highlight the impact of new classification criteria on research.
  • To identify current therapeutic approaches and existing research gaps.

Main Methods:

  • Literature review of pediatric small vessel vasculitides.
  • Discussion of clinical manifestations and current therapies.
  • Analysis of existing clinical trial data and future research needs.

Main Results:

  • New validated classification criteria for HSP and Wegener's granulomatosis will aid future research.
  • Clinical manifestations of pediatric small vessel vasculitis are described.
  • Limited randomized controlled trial (RCT) data exists for HSP and pediatric AAV therapies.
  • Children with AAV are now included in an RCT comparing mycophenolate mofetil and cyclophosphamide.

Conclusions:

  • Validated classification criteria are a significant step forward for pediatric vasculitis research.
  • There is a critical need for robust clinical trial data and validated outcome measures for HSP and AAV.
  • Long-term outcome data for pediatric small vessel vasculitis survivors are lacking.
  • Further research is essential to improve diagnosis, treatment, and long-term management of these conditions.